When we compared the normalized counts of these immune checkpoints across the pediatric GCT subtypes (Figure 5A), we found that dysgerminoma showed significantly higher expression of IDO1 and CTLA4 than the control group. This evidence concerns the gene IDO1 and granular cell tumor.